XI.2

2. Butter

The rehabilitated fat — CLA, butyric-acid origin, and the metabolic paradox of full-fat dairy.

Source: Bos taurus cow milk fat (Bovidae); minimum 80% milk fat (EU 1308/2013)Main_bioactives: short- and medium-chain saturated fatty acids (butyric C4, caprylic C8, myristic C14, palmitic C16), fat-soluble vitamins (A, D, E, K2), conjugated linoleic acid (CLA), phospholipids (MFGM)FODMAP: low (lactose < 0.1 g / 100 g)Evidence_level: ★★ (observational meta-analyses — neutral CVD association; intervention RCTs show LDL-raising effect)Microbiota_position: trace butyrate (butyric acid) as direct colonocyte fuel; MFGM phospholipids show documented immunomodulatory effect in infants

Butter in 1 minute

What does it provide? A complex milk-fat matrix: - Fat-soluble vitamins: A (retinol — vision, immunity), D (bones, immunity — higher in pasture-fed butter), K2 (menaquinone, directs calcium to bones/vessels — notably higher in pasture butter), E (tocopherol). - Butyric acid (butyrate, C4 SFA, 3–4%): the main fuel of colonocytes; the amount from butter is small and absorbed in the small intestine (does NOT feed the colon) — the clinical source is rather fiber fermentation by the microbiome. - CLA (conjugated linoleic acid): a natural ruminant-derived isomer with anti-inflammatory and body-composition modulating potential; ~3–5× more in pasture butter. - MFGM (Milk Fat Globule Membrane, phospholipids + glycoproteins): immunomodulatory and prebiotic matrix (Timby 2014 infant RCT — lower infection rate).[1889]

How much? 10–20 g/day (1–2 tablespoons) is acceptable in a balanced diet. In Hungarian peasant-butter tradition: on bread, on cooked vegetables, in cakes.

When to avoid? Severe hypercholesterolemia (familial form), confirmed milk-protein allergy (casein), certain biliary disease flares. With lactose intolerance it is generally tolerated (very low lactose content).

📜 Historical Overview

Butter-making is nearly as old as cattle domestication itself: the earliest archaeological butter remains were found in Irish peat bogs as "bog butter" sealed in wooden vessels, dating back roughly 4,000 years. In ancient Mesopotamia it served as a sacred sacrificial substance, in Egypt as a cosmetic, in Scandinavia as a means of paying taxes. In the Central European shepherd cultures, "peasant butter" made with churn and wooden butter pot was the fat source of long winter months, with a mildly tangy, ripened flavor due to unrefrigerated storage — this flavor echoes today in European PDO butters (e.g., Beurre d'Isigny).

The mid-20th century brought a radical turn: Ancel Keys's 1953 "Seven Countries Study" and the subsequent American dietary guidelines named saturated fat as the chief culprit behind cardiovascular disease. Margarine appeared as the "healthy" alternative — later it turned out that partially hydrogenated margarine containing trans-fatty acids was substantially more harmful to cardiovascular risk than butter itself (FDA 2015 trans-fat ban). In the 21st century, the de Souza (BMJ 2015) and Dehghan (PURE Lancet 2017) meta-analyses found no clear link between SFA intake and CVD mortality — the question became more nuanced, and butter regained its culinary legitimacy within the "matrix hypothesis" (Astrup et al.).

Scientific Background

Butter's fatty-acid profile: roughly 50–65% saturated fatty acids (palmitic, myristic, stearic, smaller proportions of butyric C4 and caprylic-capric C8–C10), 25–30% monounsaturated (oleic), and only 2–5% polyunsaturated. It also contains natural trans-fatty acids (vaccenic acid, CLA) formed in the ruminant rumen — these are metabolically more favorable than industrial trans fats.

The earlier linear "SFA → LDL → CVD" chain has been substantially revised: intervention RCTs still show LDL-raising effects from butter consumption (Brassard 2017, roughly +0.16 mmol/L for butter vs. olive oil)[1888], but the population-level CVD outcome association is weak (de Souza BMJ 2015, Dehghan PURE Lancet 2017).[1885][1886] According to the "matrix hypothesis" (Astrup et al. Am J Clin Nutr 2020), the dairy-fat matrix (MFGM phospholipids, calcium, protein context) modulates the biological effect of SFA — this explains why butter and cheese do not show the same CVD risk.[1887]

At the microbiome level, butter contains a small amount of butyrate (short-chain C4) — but this is absorbed in the small intestine and does NOT reach the colon, where microbiome-derived butyrate acts. The argument "I eat butter to feed butyrate to my microbiome" is therefore physiologically incorrect. MFGM phospholipids, however, have prebiotic and immunomodulatory potential — a documented effect in infant-feeding RCTs (Timby 2014).

✅ Combine with

+ Whole-grain bread, legumes: the fat-soluble vitamins (A, D, K2) of butter need a fat matrix for absorption; complex fiber-carbohydrate stabilizes the glycemic response.
+ Carrot, winter squash, leafy greens: carotenoid (β-carotene) and vitamin K1 absorption multiplies in the presence of fat — butter-cooked carrots aren't tradition fetish, they're biochemistry.
+ Eggs: shared source of fat-soluble vitamins (A, D, K2), classic scrambled-egg combination.
+ Citrus, peppers (vitamin C): antioxidant protection for butter's vitamin A and β-carotene content.
+ Fermented dairy (kefir, yogurt): synergistic dairy matrix, live-culture nutrients give complementary gut-flora effects.
+ Spices (turmeric, garlic, fresh herbs): helps the release of fat-soluble polyphenols and essential oils — the Indian ghee "tarka" tempering principle applies to butter too.

🚫 Avoid combining with

High-temperature cooking (≥ 175 °C, prolonged): the milk-protein residues (casein traces) of butter burn and form acrylamide and oxidized fatty-acid products. For frying, use ghee or a high-smoke-point oil (avocado, refined canola).
Severe hypercholesterolemia diet: if the LDL target cannot be reached with statins and diet, reducing butter (toward unsaturated alternatives) is clinically justified.
Calcium-channel blockers (nifedipine, amlodipine) and grapefruit sensitivity: no direct butter interaction, but a high-fat breakfast can modify the absorption of certain drugs (e.g., fenofibrate, posaconazole) — consult a physician.
Margarine-butter blends ("light butter"): many commercial products contain partially hydrogenated vegetable oil and emulsifying additives — trans-fat content is a risk. Read labels.
Milk-protein allergy (casein): butter contains small casein traces — in strict IgE-mediated allergy this can still trigger a reaction. Ghee (see next chapter) is a safer choice.
Active biliary disease flare, cholesterol gallstone attack: a high-fat meal can provoke gallbladder emptying — temporarily reduce.

⚠️ When to avoid — condition-specific

Familial (heterozygous) hypercholesterolemia, confirmed ASCVD: clinical guidelines (ESC 2019, AHA 2021) require saturated fat to stay at 6–7% of energy[1890][1891] — that's about 13–16 g SFA/day, into which a butter portion (10 g butter ≈ 5 g SFA) fits only in a limited way.
IgE-mediated milk-protein allergy (casein): avoid — even butter's small protein content can trigger a reaction.
Active cholesterol gallstone attack, cholecystitis: temporary fat restriction is warranted.
Severe NAFLD/NASH: SFA reduction is part of treatment, small amounts of butter still fit but should not be emphasized.
Acute phase of severe pancreatitis: strict fat-restricted diet required.
Chronic steatorrhea (cystic fibrosis, pancreatic insufficiency): without fat-digesting enzyme replacement (pancreatin), fat is not absorbed.
ApoE ε4/ε4 genotype: higher dietary SFA sensitivity — individual LDL monitoring required.
Lactose intolerance: generally tolerated (< 0.1 g lactose/100 g butter); in severe cases ghee is recommended.

❌ Myths and their refutation

"Butter is unhealthy because of the saturated fat."❌ Modern meta-analyses (de Souza BMJ 2015, Dehghan PURE Lancet 2017, Astrup Am J Clin Nutr 2020) do not show a clear association between SFA intake and CVD mortality when SFA comes from a whole dairy matrix (butter, cheese, yogurt). Clinical guidelines still limit SFA amount, but science has moved beyond the image of butter as a "universal poison."

"Margarine is healthier than butter."❌ A historical myth. The trans-fatty acid content of partially hydrogenated margarine (1990s) demonstrably raised CVD risk — so much so that the FDA banned partial hydrogenation in 2015.[1892] Modern "non-hydrogenated" margarine is safer, but does not surpass butter in flavor or matrix effects.

"Butter improves gut flora because it contains butyric acid."❌ Physiologically incorrect: butter's short-chain butyric acid (C4) is absorbed in the small intestine and does NOT reach the colon, where microbiome-derived butyrate acts on colonocytes. Colonic butyrate is fed by fiber fermentation (resistant starch, inulin, β-glucan), not by butter consumption.

"Grass-fed butter is much better."⚠️ Partly true. The CLA, omega-3, and K2 content of pasture-fed cow's milk and butter is indeed higher (roughly 2–5×), but the absolute values are still low — population-level effect on CVD risk is not documented. "Grass-fed butter" is a premium price for premium quality, but not a miracle.

"Butter makes you lose weight because it's ketogenic."❌ The ketogenic diet is a specific therapeutic tool (childhood epilepsy, experimental therapy for severe insulin resistance). The "bulletproof coffee" hype offers no weight-loss benefit vs. calorie deficit on a normal diet.

"Irish/French/Normandy butter beats domestic butter on every level."⚠️ PDO butters (Beurre d'Isigny, Kerrygold) are made with long aging tradition and pasture feeding — their flavor profile is more nuanced. The nutritional value of domestic, good-quality (≥ 82% milk fat) peasant butter, however, is not lower.

🍳 Kitchen Protocol

Daily serving: 10–20 g (1–2 tablespoons) — on bread, on cooked vegetables, on steamed fish.

Preparation pattern:

Soften butter taken from the fridge at room temperature for 30 minutes (spreadability).
For cooking: max 150 °C — beyond browning, acrylamide and oxidized products form.
Combined use: start in oil (high smoke point) → butter at the end for flavor ("beurre noisette" technique).

Classic patterns:

Rustic buttered toast: rustic bread + butter + radish + scallion — healthy, fiber-rich matrix
Butter-cooked carrots: carotenoids in a fat matrix → multiplied absorption
Beurre blanc sauce: butter + white wine + shallot — French classic, accompaniment to fish
Golden butter mashed potatoes: potato + butter + milk + nutmeg — emotional comfort and nutrient density

Storage: in the fridge in an airtight container (it absorbs odors), max 4 weeks. Frozen 6 months. Always cut butter with a clean knife (to avoid microbial contamination).

What not to do: don't heat at high temperatures for long (burnt casein residues), don't store in plastic packaging on the fridge door, don't substitute "light butter" (margarine blend) into traditional recipes.

References

[1885] de Souza RJ et al. Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies. BMJ 2015;351:h3978. . 2015. Link

OBJECTIVE: To systematically review associations between intake of saturated fat and trans unsaturated fat and all cause mortality, cardiovascular disease (CVD) and associated mortality, coronary heart disease (CHD) and associated mortality, ischemic stroke, and type 2 diabetes. DESIGN: Systematic review and meta-analysis. DATA SOURCES: Medline, Embase, Cochrane Central Registry of Controlled Trials, Evidence-Based Medicine Reviews, and CINAHL from inception to 1 May 2015, supplemented by bibliographies of retrieved articles and previous reviews. ELIGIBILITY CRITERIA FOR SELECTING STUDIES: Observational studies reporting associations of saturated fat and/or trans unsaturated fat (total, industrially manufactured, or from ruminant animals) with all cause mortality, CHD/CVD mortality, total CHD, ischemic stroke, or type 2 diabetes. DATA EXTRACTION AND SYNTHESIS: Two reviewers independently extracted data and assessed study risks of bias. Multivariable relative risks were pooled.

[1886] Dehghan M et al. Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study. Lancet 2017;390(10107):2050–2062. . 2017. Link

BACKGROUND: The relationship between macronutrients and cardiovascular disease and mortality is controversial. Most available data are from European and North American populations where nutrition excess is more likely, so their applicability to other populations is unclear. METHODS: The Prospective Urban Rural Epidemiology (PURE) study is a large, epidemiological cohort study of individuals aged 35-70 years (enrolled between Jan 1, 2003, and March 31, 2013) in 18 countries with a median follow-up of 7·4 years (IQR 5·3-9·3). Dietary intake of 135 335 individuals was recorded using validated food frequency questionnaires. The primary outcomes were total mortality and major cardiovascular events (fatal cardiovascular disease, non-fatal myocardial infarction, stroke, and heart failure). Secondary outcomes were all myocardial infarctions, stroke, cardiovascular disease mortality, and non-cardiovascular disease mortality.

[1887] Astrup A et al. Saturated fats and health: a reassessment and proposal for food-based recommendations. Am J Clin Nutr 2020;112(5):1080–1082. . 2020. Link

Opinion reassessing saturated fats and health, with a proposal for food-based recommendations.

[1888] Brassard D et al. Comparison of the impact of SFAs from cheese and butter on cardiometabolic risk factors: a randomized controlled trial. Am J Clin Nutr 2017;105(4):800–809. . 2017. Link

Background: Controversies persist concerning the association between intake of dietary saturated fatty acids (SFAs) and cardiovascular disease risk.Objective: We compared the impact of consuming equal amounts of SFAs from cheese and butter on cardiometabolic risk factors.Design: In a multicenter, crossover, randomized controlled trial, 92 men and women with abdominal obesity and relatively low HDL-cholesterol concentrations were assigned to sequences of 5 predetermined isoenergetic diets of 4 wk each separated by 4-wk washouts: 2 diets rich in SFAs (12.4-12.6\% of calories) from either cheese or butter; a monounsaturated fatty acid (MUFA)-rich diet (SFAs: 5.8\%, MUFAs: 19.6\%); a polyunsaturated fatty acid (PUFA)-rich diet (SFAs: 5.8\%, PUFAs: 11.5\%); and a low-fat, high-carbohydrate diet (fat: 25\%, SFAs: 5.8\%).Results: Serum HDL-cholesterol concentrations were similar after the cheese and butter diets but were significantly higher than after the carbohydrate diet (+3.8\% and +4.7\%, respectively; P < 0.05 for both). LDL-cholesterol concentrations after the cheese diet were lower than after the butter diet (-3.3\%, P < 0.05) but were higher than after the carbohydrate (+2.6\%), MUFA (+5.3\%), and PUFA (+12.3\%) diets (P < 0.05 for all). LDL-cholesterol concentrations after the butter diet also increased significantly (from +6.1\% to +16.2\%, P < 0.05) compared with the carbohydrate, MUFA, and PUFA diets. The LDL-cholesterol response to treatment was significantly modified by baseline values (P-interaction = 0.02), with the increase in LDL cholesterol being significantly greater with butter than with cheese only among individuals with high baseline LDL-cholesterol concentrations. There was no significant difference between all diets on inflammation markers, blood pressure, and insulin-glucose homeostasis.Conclusions: The results of our study suggest that the consumption of SFAs from cheese and butter has similar effects on HDL cholesterol but differentially modifies LDL-cholesterol concentrations compared with the effects of carbohydrates, MUFAs, and PUFAs, particularly in individuals with high LDL cholesterol. In contrast, SFAs from either cheese or butter have no significant effects on several other nonlipid cardiometabolic risk factors.

[1889] Timby N et al. Neurodevelopment, nutrition, and growth until 12 mo of age in infants fed a low-energy, low-protein formula supplemented with bovine milk fat globule membranes: a randomized controlled trial. Am J Clin Nutr 2014;99(4):860–868. . 2014. Link

BACKGROUND: Observational studies have indicated that differences in the composition of human milk and infant formula yield benefits in cognitive development and early growth for breastfed infants. OBJECTIVE: The objective was to test the hypothesis that feeding an infant formula with reduced energy and protein densities and supplemented with bovine milk fat globule membrane (MFGM) reduces differences in cognitive development and early growth between formula-fed and breastfed infants. DESIGN: In a prospective, double-blind, randomized controlled trial, 160 infants <2 mo of age were randomly assigned to be fed an MFGM-supplemented, low-energy, low-protein experimental formula (EF) or a standard formula (SF) until 6 mo of age. The energy and protein contents of the EF and SF were 60 and 66 kcal/100 mL and 1.20 and 1.27 g/100 mL, respectively. A breastfed reference (BFR) group consisted of 80 infants. RESULTS: At 12 mo of age, the cognitive score (mean ± SD) on testing with the Bayley Scales of Infant and Toddler Development, Third Edition, was significantly higher in the EF group than in the SF group (105.8 ± 9.2 compared with 101.8 ± 8.0; P = 0.008) but was not significantly different from that in the BFR group (106.4 ± 9.5; P = 0.73).

[1890] EFSA Panel. Scientific Opinion on Dietary Reference Values for fats. EFSA Journal 2010;8(3):1461. . 2010. Link

EFSA Panel scientific opinion on Dietary Reference Values for fats.

[1891] ESC/EAS Guidelines for the management of dyslipidaemias. Eur Heart J 2020;41(1):111–188. . 2020. Link

ESC/EAS Guidelines for the management of dyslipidaemias.

[1892] FDA. Final Determination Regarding Partially Hydrogenated Oils. Federal Register 2015;80(116):34650–34670. . 2015. Link

FDA Final Determination regarding partially hydrogenated oils.